Levosimendan Versus Dobutamine in Cardiopatic Patients Undergoing Major Non Cardiac Surgery

Phase 4UnknownNCT02012946

Azienda Policlinico Umberto I40 enrolled

Overview

This study wants to investigate the hemodynamic changes in cardiopatic patients undergoing major non cardiac surgery, during and after the continuous infusion of levosimendan or dobutamine.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Cardiovascular Diseases

Interventions

LevosimendanDRUG

patient receiving levosimendan

DobutamineDRUG

patient receiving dobutamine

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * EF \< 40%, no liver and renal disfynction, chronic cardiopathy Exclusion Criteria: * acute coronary syndrome, life expectation \<30 days, hemodialysis, ventricular tachycardia/ventricular fibrillation

Locations (1)

Francesco Pugliese

Rome, Rome, Italy

Outcomes

Primary Outcomes

cardiac index

Time frame: 1-3 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.